DRIO
DarioHealth Corp

3,560
Loading...
Loading...
News
all
press releases
Merit Medical Expands GI Portfolio With $22M C2 CryoBalloon Acquisition
MMSI is set to acquire C2 CryoBalloon from Pentax for $22M, strengthening its GI portfolio. Despite near-term dilution, the deal positions Merit for long-term growth in gastroenterology.
Zacks·3d ago
News Placeholder
More News
News Placeholder
Wall Street Analysts Predict a 42.77% Upside in DarioHealth (DRIO): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 42.8% in DarioHealth (DRIO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·5d ago
News Placeholder
Dario Signs 6 New Employer Clients Representing Tens of Thousands of Lives Deepening its Leadership in Value-Based Care
Dario Signs 6 New Employer Clients Representing Tens of Thousands of Lives Deepening its Leadership in Value-Based Care Dario Signs 6 New Employer Clients Representing Tens of Thousands of Lives...
PR Newswire·6d ago
News Placeholder
DarioHealth Corp. (DRIO) Reports Q2 Loss, Misses Revenue Estimates
DarioHealth (DRIO) delivered earnings and revenue surprises of -9.09% and -22.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates
Sight Sciences (SGHT) delivered earnings and revenue surprises of +8.00% and +8.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
CVRx (CVRX) Reports Q2 Loss, Beats Revenue Estimates
CVRx (CVRX) delivered earnings and revenue surprises of -9.62% and +0.96%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
TransMedics (TMDX) Q2 Earnings and Revenues Surpass Estimates
TransMedics (TMDX) delivered earnings and revenue surprises of +91.67% and +6.79%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue Estimates
Zacks·5mo ago
News Placeholder
KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
chainwire·5mo ago
News Placeholder
Market News Alert: DarioHealth Secures Significant New Agreement, Expanding Growth in the $1.2 Trillion Dollar Cardiometabolic Market
Market News Alerts Updates: DarioHealth Corp. (Nasdaq: DRIO)* has announced a significant new agreement with a Blue Cross Blue Shield (BCBS) health plan, marking a pivotal expansion in the...
Business Wire·8mo ago

Latest DRIO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.